Clinical Trial Update: Efficacy and Safety of Diosmin 600mg Versus Placebo on Painful Symptomatology in Patients With Chronic Venous Disease of Lower Limbs [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Diosmin 600 mg to placebo in chronic venous disease of the lower limbs has been completed, reporting on efficacy and safety outcomes.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Venous Disease of the Lower Limbs

Drugs mentioned

• Diosmin (Diosmin)

Snippet

Sponsor: Laboratoire Innotech International | Conditions: Chronic Venous Disease of Lower Limbs | Phase 3 | Status: COMPLETED